Distribution of UICC-Equivalent Relapse Stages According to Upfront Imaging Strategy
| Stage | CXR/MRI† | CCT*/MRI† | PET/CT |
| Localized | 44 (40%) | 27 (25%) | 23 (21%) |
| Stage 0‡ | 6 (5%) | 5 (5%) | 1 (1%) |
| Stage I | 22 (20%) | 13 (12%) | 14 (13%) |
| Stage II | 16 (15%) | 9 (8%) | 8 (7%) |
| Locally advanced | 59 (54%) | 48 (44%) | 50 (45%) |
| Stage III | 20 (18%) | 13 (12%) | 13 (12%) |
| Stage IVA | 35 (32%) | 31 (28%) | 32 (29%) |
| Stage IVB | 4 (4%) | 4 (4%) | 5 (4%) |
| Metastatic (stage IVC) | 7 (6%) | 35 (31%) | 37 (34%) |